NKGen Biotech, Inc.
NKGNDelisted Jul 17, 2025- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001845459
NKGen Biotech, Inc. was delisted on Jul 17, 2025; its insiders filed their last Form 4 on Jun 2, 2025; no institution reported holding it in 13F filings for Q2 2025; no superinvestor held it.
Holders of 5% or more of NKGN
Holders whose latest Schedule 13D or 13G filing reports 5% or more of NKGen Biotech, Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Song Paul Y. | 13D | 54.30%63.7M shares | New | May 12, 20251 filing | May 12, 2025 | SEC |
| CFIC-2015 NV Family Investments, LLC | 13D | 47.20%63.2M shares | – | Aug 22, 20242 filings | Jun 2, 2025 | SEC |
| Pathstone Family Office, LLC | 13G | 7.91%2.80M shares | New | Feb 28, 20251 filing | Feb 28, 2025 | SEC |
| Meteora Capital, LLC | 13G/A | 6.13%2.76M shares | −1.71 ppfrom 7.84% | Feb 14, 20244 filings | May 15, 2025 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
18 Schedule 13D and 13G filings on NKGen Biotech, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Jun 2, 202512:12 PM ET | CFIC-2015 NV Family Investments, LLCand 2 others | 13D | 47.20%63.2M shares | – | May 27, 2025 | SEC |
| May 15, 202512:29 PM ET | Meteora Capital, LLCand 1 other | 13G/A | 6.13%2.76M shares | −1.71 ppfrom 7.84% | Mar 31, 2025 | SEC |
| May 12, 20254:15 PM ET | Song Paul Y. | 13D | 54.30%63.7M shares | New | May 5, 2025 | SEC |
| Feb 28, 20255:46 PM ET | Pathstone Family Office, LLC | 13G | 7.91%2.80M shares | New | Oct 17, 2024 | SEC |
| Feb 14, 202510:34 AM ET | Meteora Capital, LLCand 1 other | 13G/A | 7.84%2.77M shares | – | Dec 31, 2024 | SEC |
| Aug 22, 2024 | CFIC-2015 NV Family Investments, LLC | 13GOld format | – | New | – | SEC |
| May 10, 2024 | Meteora Capital, LLC | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2024 | Meteora Capital, LLC | 13GOld format | – | New | – | SEC |
| Feb 14, 2024 | Radcliffe Capital Management, L.P. | 13G/AOld format | – | – | – | SEC |
| Feb 7, 2024 | Adage Capital Partners GP, L.L.C. | 13G/AOld format | – | – | – | SEC |
| Dec 19, 2023 | NKMAX Co., Ltd. | 13D/AOld format | – | – | – | SEC |
| Oct 10, 2023 | NKMAX Co., Ltd. | 13DOld format | – | New | – | SEC |
| May 23, 2023 | Radcliffe Capital Management, L.P. | 13GOld format | – | New | – | SEC |
| Jan 25, 2023 | Highbridge Capital Management LLC | 13G/AOld format | – | – | – | SEC |
| Feb 11, 2022 | Graf Acquisition Partners IV LLC | 13GOld format | – | New | – | SEC |
| Feb 3, 2022 | Highbridge Capital Management LLC | 13G/AOld format | – | – | – | SEC |
| Jul 9, 2021 | Highbridge Capital Management LLC | 13GOld format | – | New | – | SEC |
| Jun 4, 2021 | Adage Capital Partners GP, L.L.C. | 13GOld format | – | New | – | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell NKGen Biotech, Inc. shares.
No Form 144 notices for NKGen Biotech, Inc. are on file.